CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Aclaris Therapeutics - CapyFin

Aclaris Therapeutics

ACRS · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $2.77M

Previous year: -$0.15

Previous year: $8.76M

Previous year: $4.75M

Licensing expenses

Previous year: $1.29M

Cash and Equivalents

Previous year: $150M

Previous year: $161M

Loading...

Key Statistics

Market Cap

$380M

P/E Ratio

-2.54

Sector

N/A

Industry

N/A

52-Week High

$4.5

52-Week Low

$1.05

R&D expenses

$11.4M

G&A expenses

$5.39M

Licensing expenses

$1.34M

Revaluation of contingent consideration

$1.5M

Interest income

$2.02M

Aclaris Therapeutics

Unlock previous datapoints

Aclaris Therapeutics

Unlock previous datapoints

Aclaris Therapeutics Revenue by Segment

Revenue by Segment

Contract research Revenue

CapyFin.com

Licensing Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...